Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Cancer, Biomarkers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06657755
What this trial is testing

Evaluation of ENPP1 Expression and Immune Response in Bladder Cancer Patients

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Lanzhou University Second Hospital 12
Not applicableUnknownNCT00244205
What this trial is testing

Identifying Methylation Biomarkers for Monitoring Bladder Tumors

Who this might be right for
Bladder Cancer
Copenhagen University Hospital at Herlev 120
Not applicableLooking for participantsNCT07038928
What this trial is testing

TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation

Who this might be right for
Bladder Cancer
AstraZeneca 600
Not applicableStudy completedNCT02756637
What this trial is testing

Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710

Who this might be right for
Bladder Cancer
Abramson Cancer Center at Penn Medicine 634
Not applicableStudy completedNCT03066310
What this trial is testing

Urine-DNA Biomarkers in Detecting Bladder Cancer

Who this might be right for
Bladder CancerBiomarkerDiagnosis+1 more
Xiangya Hospital of Central South University 125
Testing effectiveness (Phase 2)UnknownNCT03263039
What this trial is testing

Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab

Who this might be right for
Transitional Cell Carcinoma of the BladderBiomarkers
Erasmus Medical Center 80
Not applicableUnknownNCT05685524
What this trial is testing

Clinical Study of Pan-cancer DNA Methylation Test in Plasma

Who this might be right for
Cancer
Wuhan Ammunition Life-tech Co., Ltd 3,000
Not applicableLooking for participantsNCT03413982
What this trial is testing

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Who this might be right for
Bladder Cancer
University of Kansas Medical Center 1,000
Testing effectiveness (Phase 2)Study completedNCT02007005
What this trial is testing

Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Abnoba Gmbh 37
Not applicableStudy completedNCT05671289
What this trial is testing

Urine VOC Investigation in Bladder Cancer Diagnosis

Who this might be right for
Bladder Cancer
First Affiliated Hospital Xi'an Jiaotong University 77
Not applicableLooking for participantsNCT03787056
What this trial is testing

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Who this might be right for
CancerBreast CancerGastric Cancer+14 more
Hospices Civils de Lyon 410
Not applicableActive Not RecruitingNCT06870253
What this trial is testing

Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases

Who this might be right for
Bladder CancerUrothelial Carcinoma Bladder
Pangea Laboratory LLC 80
Not applicableEnded earlyNCT02494635
What this trial is testing

Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer

Who this might be right for
Bladder Papillary Urothelial CarcinomaStage 0a Bladder Urothelial CarcinomaStage 0is Bladder Urothelial Carcinoma+5 more
University of Southern California 4
Not applicableActive Not RecruitingNCT07252297
What this trial is testing

The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Xijing Hospital 177
Early research (Phase 1)WithdrawnNCT04972253
What this trial is testing

Phase I BLASST-3 Trial

Who this might be right for
Bladder Transitional Cell CarcinomaBladder CancerFibroblast Growth Factor Receptor
Guru P. Sonpavde
Not applicableUnknownNCT04966975
What this trial is testing

Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 60
Not applicableStudy completedNCT06235853
What this trial is testing

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerCystoscopyRecurrence+3 more
Wroclaw Medical University 240
Not applicableStudy completedNCT00900276
What this trial is testing

Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants

Who this might be right for
Bladder CancerKidney CancerTransitional Cell Cancer of the Renal Pelvis and Ureter+1 more
Wake Forest University Health Sciences 5
Not applicableLooking for participantsNCT07036731
What this trial is testing

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Not applicableEnded earlyNCT05052372
What this trial is testing

Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib

Who this might be right for
Bladder CancerUrothelial CarcinomaTransitional Cell Carcinoma+10 more
xCures 2
Next Page